PATENT CLAIM ANALYSIS

Application Number: 15864155
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "026000"]

Abstract:
This invention relates to a topical composition for prevention and treatment of viral infections.

Claim (Index 4):
A pharmaceutical topical gel formulation as claimed in  claim 1 , wherein the diuretic is selected from the group consisting of furosemide, bumetanide, ethacrynic acid, torsemide, muzolimide, azosemide, piretanide, tripamide, chlorothiazide, hydrochlorothiazide, chlorthandone, indapamide, metozalone, cyclopenthiazide, xipamide, mefruside, dorzolamide, acetazolamide, methazolamide, ethoxzolamide, cyclothiazide, clopamide, dichlorphenamide, hydroflumethiazide, trichlormethiazide, polythiazide, benzothiazide, and combinations thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15266388', '15266165', '15171646', '12598102', '15695206']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8416971458147776
- 35 USC 102 Novelty (BERT): 0.5614706239930599
- Combined Prediction Score: 0.8136744936326059
- Mean Citation Score: 368.171132
- Max Citation Score: 479.91364
- Similarity Product: 331.36676246994017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test